MedTrace Logo

Evaluation of the Efficacy of Radiofrequency in the Treatment of Renal Tumors

NCT02850809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 310

Last updated 2023-04-28

No results posted yet for this study

Summary

Multi-institutional registry on a cohort of 310 patients with biopsy-proven renal cell carcinoma treated by Radiofrequency ablation. All patients will be included consecutively and retrospectively in all centers to obtain the required number of patient followed during 5 years.

Conditions

Sponsors & Collaborators

  • Ministry for Health and Solidarity, France

    collaborator OTHER_GOV

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Paul PEREZ, MD · University Hospital Bordeaux, France

  • Nicolas GRENIER, Prof · University Hospital Bordeaux, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02850809 on ClinicalTrials.gov